+1 347 708 0418
The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2017 to 2028. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
Segment by Type
Cobalt-chromium Alloy Stents
Magnesium Alloy Stents
Stainless Steel Stents
Others
Segment by Application
Hospital
Specialty Clinic
Others
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
By Company
Abbott
Medtronic Vascular
Advantec Vascular
B.Braun Melsengen
Boston Scientific
Terumo Medical
Biosensors
Biotronik
Blue Medical
DISA Vascular
Essen
MicroPort Medical
MIV Therapeutics
Orbusneich
Promed Medical
Relisys Medical
Reva Medical
Sahajanand
Sino Medical
Sorin
TEDA
1 Intracranial Drug Eluting Stents Market Overview
1.1 Product Overview and Scope of Intracranial Drug Eluting Stents
1.2 Intracranial Drug Eluting Stents Segment by Type
1.2.1 Global Intracranial Drug Eluting Stents Sales Growth Rate Comparison by Type (2022-2028)
1.2.2 Cobalt-chromium Alloy Stents
1.2.3 Magnesium Alloy Stents
1.2.4 Stainless Steel Stents
1.2.5 Others
1.3 Intracranial Drug Eluting Stents Segment by Application
1.3.1 Global Intracranial Drug Eluting Stents Sales Comparison by Application: (2022-2028)
1.3.2 Hospital
1.3.3 Specialty Clinic
1.3.4 Others
1.4 Global Intracranial Drug Eluting Stents Market Size Estimates and Forecasts
1.4.1 Global Intracranial Drug Eluting Stents Revenue 2017-2028
1.4.2 Global Intracranial Drug Eluting Stents Sales 2017-2028
1.4.3 Intracranial Drug Eluting Stents Market Size by Region: 2017 Versus 2021 Versus 2028
2 Intracranial Drug Eluting Stents Market Competition by Manufacturers
2.1 Global Intracranial Drug Eluting Stents Sales Market Share by Manufacturers (2017-2022)
2.2 Global Intracranial Drug Eluting Stents Revenue Market Share by Manufacturers (2017-2022)
2.3 Global Intracranial Drug Eluting Stents Average Price by Manufacturers (2017-2022)
2.4 Manufacturers Intracranial Drug Eluting Stents Manufacturing Sites, Area Served, Product Type
2.5 Intracranial Drug Eluting Stents Market Competitive Situation and Trends
2.5.1 Intracranial Drug Eluting Stents Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Intracranial Drug Eluting Stents Players Market Share by Revenue
2.5.3 Global Intracranial Drug Eluting Stents Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Intracranial Drug Eluting Stents Retrospective Market Scenario by Region
3.1 Global Intracranial Drug Eluting Stents Retrospective Market Scenario in Sales by Region: 2017-2022
3.2 Global Intracranial Drug Eluting Stents Retrospective Market Scenario in Revenue by Region: 2017-2022
3.3 North America Intracranial Drug Eluting Stents Market Facts & Figures by Country
3.3.1 North America Intracranial Drug Eluting Stents Sales by Country
3.3.2 North America Intracranial Drug Eluting Stents Revenue by Country
3.3.3 United States
3.3.4 Canada
3.4 Europe Intracranial Drug Eluting Stents Market Facts & Figures by Country
3.4.1 Europe Intracranial Drug Eluting Stents Sales by Country
3.4.2 Europe Intracranial Drug Eluting Stents Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Intracranial Drug Eluting Stents Market Facts & Figures by Region
3.5.1 Asia Pacific Intracranial Drug Eluting Stents Sales by Region
3.5.2 Asia Pacific Intracranial Drug Eluting Stents Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 China Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.6 Latin America Intracranial Drug Eluting Stents Market Facts & Figures by Country
3.6.1 Latin America Intracranial Drug Eluting Stents Sales by Country
3.6.2 Latin America Intracranial Drug Eluting Stents Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.6.6 Colombia
3.7 Middle East and Africa Intracranial Drug Eluting Stents Market Facts & Figures by Country
3.7.1 Middle East and Africa Intracranial Drug Eluting Stents Sales by Country
3.7.2 Middle East and Africa Intracranial Drug Eluting Stents Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 UAE
4 Global Intracranial Drug Eluting Stents Historic Market Analysis by Type
4.1 Global Intracranial Drug Eluting Stents Sales Market Share by Type (2017-2022)
4.2 Global Intracranial Drug Eluting Stents Revenue Market Share by Type (2017-2022)
4.3 Global Intracranial Drug Eluting Stents Price by Type (2017-2022)
5 Global Intracranial Drug Eluting Stents Historic Market Analysis by Application
5.1 Global Intracranial Drug Eluting Stents Sales Market Share by Application (2017-2022)
5.2 Global Intracranial Drug Eluting Stents Revenue Market Share by Application (2017-2022)
5.3 Global Intracranial Drug Eluting Stents Price by Application (2017-2022)
6 Key Companies Profiled
6.1 Abbott
6.1.1 Abbott Corporation Information
6.1.2 Abbott Description and Business Overview
6.1.3 Abbott Intracranial Drug Eluting Stents Sales, Revenue and Gross Margin (2017-2022)
6.1.4 Abbott Intracranial Drug Eluting Stents Product Portfolio
6.1.5 Abbott Recent Developments/Updates
6.2 Medtronic Vascular
6.2.1 Medtronic Vascular Corporation Information
6.2.2 Medtronic Vascular Description and Business Overview
6.2.3 Medtronic Vascular Intracranial Drug Eluting Stents Sales, Revenue and Gross Margin (2017-2022)
6.2.4 Medtronic Vascular Intracranial Drug Eluting Stents Product Portfolio
6.2.5 Medtronic Vascular Recent Developments/Updates
6.3 Advantec Vascular
6.3.1 Advantec Vascular Corporation Information
6.3.2 Advantec Vascular Description and Business Overview
6.3.3 Advantec Vascular Intracranial Drug Eluting Stents Sales, Revenue and Gross Margin (2017-2022)
6.3.4 Advantec Vascular Intracranial Drug Eluting Stents Product Portfolio
6.3.5 Advantec Vascular Recent Developments/Updates
6.4 B.Braun Melsengen
6.4.1 B.Braun Melsengen Corporation Information
6.4.2 B.Braun Melsengen Description and Business Overview
6.4.3 B.Braun Melsengen Intracranial Drug Eluting Stents Sales, Revenue and Gross Margin (2017-2022)
6.4.4 B.Braun Melsengen Intracranial Drug Eluting Stents Product Portfolio
6.4.5 B.Braun Melsengen Recent Developments/Updates
6.5 Boston Scientific
6.5.1 Boston Scientific Corporation Information
6.5.2 Boston Scientific Description and Business Overview
6.5.3 Boston Scientific Intracranial Drug Eluting Stents Sales, Revenue and Gross Margin (2017-2022)
6.5.4 Boston Scientific Intracranial Drug Eluting Stents Product Portfolio
6.5.5 Boston Scientific Recent Developments/Updates
6.6 Terumo Medical
6.6.1 Terumo Medical Corporation Information
6.6.2 Terumo Medical Description and Business Overview
6.6.3 Terumo Medical Intracranial Drug Eluting Stents Sales, Revenue and Gross Margin (2017-2022)
6.6.4 Terumo Medical Intracranial Drug Eluting Stents Product Portfolio
6.6.5 Terumo Medical Recent Developments/Updates
6.7 Biosensors
6.6.1 Biosensors Corporation Information
6.6.2 Biosensors Description and Business Overview
6.6.3 Biosensors Intracranial Drug Eluting Stents Sales, Revenue and Gross Margin (2017-2022)
6.4.4 Biosensors Intracranial Drug Eluting Stents Product Portfolio
6.7.5 Biosensors Recent Developments/Updates
6.8 Biotronik
6.8.1 Biotronik Corporation Information
6.8.2 Biotronik Description and Business Overview
6.8.3 Biotronik Intracranial Drug Eluting Stents Sales, Revenue and Gross Margin (2017-2022)
6.8.4 Biotronik Intracranial Drug Eluting Stents Product Portfolio
6.8.5 Biotronik Recent Developments/Updates
6.9 Blue Medical
6.9.1 Blue Medical Corporation Information
6.9.2 Blue Medical Description and Business Overview
6.9.3 Blue Medical Intracranial Drug Eluting Stents Sales, Revenue and Gross Margin (2017-2022)
6.9.4 Blue Medical Intracranial Drug Eluting Stents Product Portfolio
6.9.5 Blue Medical Recent Developments/Updates
6.10 DISA Vascular
6.10.1 DISA Vascular Corporation Information
6.10.2 DISA Vascular Description and Business Overview
6.10.3 DISA Vascular Intracranial Drug Eluting Stents Sales, Revenue and Gross Margin (2017-2022)
6.10.4 DISA Vascular Intracranial Drug Eluting Stents Product Portfolio
6.10.5 DISA Vascular Recent Developments/Updates
6.11 Essen
6.11.1 Essen Corporation Information
6.11.2 Essen Intracranial Drug Eluting Stents Description and Business Overview
6.11.3 Essen Intracranial Drug Eluting Stents Sales, Revenue and Gross Margin (2017-2022)
6.11.4 Essen Intracranial Drug Eluting Stents Product Portfolio
6.11.5 Essen Recent Developments/Updates
6.12 MicroPort Medical
6.12.1 MicroPort Medical Corporation Information
6.12.2 MicroPort Medical Intracranial Drug Eluting Stents Description and Business Overview
6.12.3 MicroPort Medical Intracranial Drug Eluting Stents Sales, Revenue and Gross Margin (2017-2022)
6.12.4 MicroPort Medical Intracranial Drug Eluting Stents Product Portfolio
6.12.5 MicroPort Medical Recent Developments/Updates
6.13 MIV Therapeutics
6.13.1 MIV Therapeutics Corporation Information
6.13.2 MIV Therapeutics Intracranial Drug Eluting Stents Description and Business Overview
6.13.3 MIV Therapeutics Intracranial Drug Eluting Stents Sales, Revenue and Gross Margin (2017-2022)
6.13.4 MIV Therapeutics Intracranial Drug Eluting Stents Product Portfolio
6.13.5 MIV Therapeutics Recent Developments/Updates
6.14 Orbusneich
6.14.1 Orbusneich Corporation Information
6.14.2 Orbusneich Intracranial Drug Eluting Stents Description and Business Overview
6.14.3 Orbusneich Intracranial Drug Eluting Stents Sales, Revenue and Gross Margin (2017-2022)
6.14.4 Orbusneich Intracranial Drug Eluting Stents Product Portfolio
6.14.5 Orbusneich Recent Developments/Updates
6.15 Promed Medical
6.15.1 Promed Medical Corporation Information
6.15.2 Promed Medical Intracranial Drug Eluting Stents Description and Business Overview
6.15.3 Promed Medical Intracranial Drug Eluting Stents Sales, Revenue and Gross Margin (2017-2022)
6.15.4 Promed Medical Intracranial Drug Eluting Stents Product Portfolio
6.15.5 Promed Medical Recent Developments/Updates
6.16 Relisys Medical
6.16.1 Relisys Medical Corporation Information
6.16.2 Relisys Medical Intracranial Drug Eluting Stents Description and Business Overview
6.16.3 Relisys Medical Intracranial Drug Eluting Stents Sales, Revenue and Gross Margin (2017-2022)
6.16.4 Relisys Medical Intracranial Drug Eluting Stents Product Portfolio
6.16.5 Relisys Medical Recent Developments/Updates
6.17 Reva Medical
6.17.1 Reva Medical Corporation Information
6.17.2 Reva Medical Intracranial Drug Eluting Stents Description and Business Overview
6.17.3 Reva Medical Intracranial Drug Eluting Stents Sales, Revenue and Gross Margin (2017-2022)
6.17.4 Reva Medical Intracranial Drug Eluting Stents Product Portfolio
6.17.5 Reva Medical Recent Developments/Updates
6.18 Sahajanand
6.18.1 Sahajanand Corporation Information
6.18.2 Sahajanand Intracranial Drug Eluting Stents Description and Business Overview
6.18.3 Sahajanand Intracranial Drug Eluting Stents Sales, Revenue and Gross Margin (2017-2022)
6.18.4 Sahajanand Intracranial Drug Eluting Stents Product Portfolio
6.18.5 Sahajanand Recent Developments/Updates
6.19 Sino Medical
6.19.1 Sino Medical Corporation Information
6.19.2 Sino Medical Intracranial Drug Eluting Stents Description and Business Overview
6.19.3 Sino Medical Intracranial Drug Eluting Stents Sales, Revenue and Gross Margin (2017-2022)
6.19.4 Sino Medical Intracranial Drug Eluting Stents Product Portfolio
6.19.5 Sino Medical Recent Developments/Updates
6.20 Sorin
6.20.1 Sorin Corporation Information
6.20.2 Sorin Intracranial Drug Eluting Stents Description and Business Overview
6.20.3 Sorin Intracranial Drug Eluting Stents Sales, Revenue and Gross Margin (2017-2022)
6.20.4 Sorin Intracranial Drug Eluting Stents Product Portfolio
6.20.5 Sorin Recent Developments/Updates
6.21 TEDA
6.21.1 TEDA Corporation Information
6.21.2 TEDA Intracranial Drug Eluting Stents Description and Business Overview
6.21.3 TEDA Intracranial Drug Eluting Stents Sales, Revenue and Gross Margin (2017-2022)
6.21.4 TEDA Intracranial Drug Eluting Stents Product Portfolio
6.21.5 TEDA Recent Developments/Updates
7 Intracranial Drug Eluting Stents Manufacturing Cost Analysis
7.1 Intracranial Drug Eluting Stents Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Intracranial Drug Eluting Stents
7.4 Intracranial Drug Eluting Stents Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Intracranial Drug Eluting Stents Distributors List
8.3 Intracranial Drug Eluting Stents Customers
9 Intracranial Drug Eluting Stents Market Dynamics
9.1 Intracranial Drug Eluting Stents Industry Trends
9.2 Intracranial Drug Eluting Stents Market Drivers
9.3 Intracranial Drug Eluting Stents Market Challenges
9.4 Intracranial Drug Eluting Stents Market Restraints
10 Global Market Forecast
10.1 Intracranial Drug Eluting Stents Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Intracranial Drug Eluting Stents by Type (2023-2028)
10.1.2 Global Forecasted Revenue of Intracranial Drug Eluting Stents by Type (2023-2028)
10.2 Intracranial Drug Eluting Stents Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Intracranial Drug Eluting Stents by Application (2023-2028)
10.2.2 Global Forecasted Revenue of Intracranial Drug Eluting Stents by Application (2023-2028)
10.3 Intracranial Drug Eluting Stents Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Intracranial Drug Eluting Stents by Region (2023-2028)
10.3.2 Global Forecasted Revenue of Intracranial Drug Eluting Stents by Region (2023-2028)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
List of Tables
Table 1. Global Intracranial Drug Eluting Stents Sales Growth Rate Comparison by Type (2022-2028) & (Units) & (US$ Million)
Table 2. Global Intracranial Drug Eluting Stents Sales Growth Rate Comparison by Application (2022-2028) & (Units) & (US$ Million)
Table 3. Global Intracranial Drug Eluting Stents Market Size by Region (US$ Million) (2017 VS 2021 VS 2028)
Table 4. Global Intracranial Drug Eluting Stents Market Competitive Situation by Manufacturers in 2021
Table 5. Global Intracranial Drug Eluting Stents Sales (Units) of Key Manufacturers (2017-2022)
Table 6. Global Intracranial Drug Eluting Stents Sales Market Share by Manufacturers (2017-2022)
Table 7. Global Intracranial Drug Eluting Stents Revenue (US$ Million) by Manufacturers (2017-2022)
Table 8. Global Intracranial Drug Eluting Stents Revenue Share by Manufacturers (2017-2022)
Table 9. Global Market Intracranial Drug Eluting Stents Average Price (US$/Unit) of Key Manufacturers (2017-2022)
Table 10. Manufacturers Intracranial Drug Eluting Stents Manufacturing Sites and Area Served
Table 11. Manufacturers Intracranial Drug Eluting Stents Product Type
Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Intracranial Drug Eluting Stents by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Intracranial Drug Eluting Stents as of 2021)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Intracranial Drug Eluting Stents Sales by Region (2017-2022) & (Units)
Table 16. Global Intracranial Drug Eluting Stents Sales Market Share by Region (2017-2022)
Table 17. Global Intracranial Drug Eluting Stents Revenue by Region (2017-2022) & (US$ Million)
Table 18. Global Intracranial Drug Eluting Stents Revenue Market Share by Region (2017-2022)
Table 19. North America Intracranial Drug Eluting Stents Sales by Country (2017-2022) & (Units)
Table 20. North America Intracranial Drug Eluting Stents Sales Market Share by Country (2017-2022)
Table 21. North America Intracranial Drug Eluting Stents Revenue by Country (2017-2022) & (US$ Million)
Table 22. North America Intracranial Drug Eluting Stents Revenue Market Share by Country (2017-2022)
Table 23. Europe Intracranial Drug Eluting Stents Sales by Country (2017-2022) & (Units)
Table 24. Europe Intracranial Drug Eluting Stents Sales Market Share by Country (2017-2022)
Table 25. Europe Intracranial Drug Eluting Stents Revenue by Country (2017-2022) & (US$ Million)
Table 26. Europe Intracranial Drug Eluting Stents Revenue Market Share by Country (2017-2022)
Table 27. Asia Pacific Intracranial Drug Eluting Stents Sales by Region (2017-2022) & (Units)
Table 28. Asia Pacific Intracranial Drug Eluting Stents Sales Market Share by Region (2017-2022)
Table 29. Asia Pacific Intracranial Drug Eluting Stents Revenue by Region (2017-2022) & (US$ Million)
Table 30. Asia Pacific Intracranial Drug Eluting Stents Revenue Market Share by Region (2017-2022)
Table 31. Latin America Intracranial Drug Eluting Stents Sales by Country (2017-2022) & (Units)
Table 32. Latin America Intracranial Drug Eluting Stents Sales Market Share by Country (2017-2022)
Table 33. Latin America Intracranial Drug Eluting Stents Revenue by Country (2017-2022) & (US$ Million)
Table 34. Latin America Intracranial Drug Eluting Stents Revenue Market Share by Country (2017-2022)
Table 35. Middle East and Africa Intracranial Drug Eluting Stents Sales by Country (2017-2022) & (Units)
Table 36. Middle East and Africa Intracranial Drug Eluting Stents Sales Market Share by Country (2017-2022)
Table 37. Middle East and Africa Intracranial Drug Eluting Stents Revenue by Country (2017-2022) & (US$ Million)
Table 38. Middle East and Africa Intracranial Drug Eluting Stents Revenue Market Share by Country (2017-2022)
Table 39. Global Intracranial Drug Eluting Stents Sales by Type (2017-2022) & (Units)
Table 40. Global Intracranial Drug Eluting Stents Sales Market Share by Type (2017-2022)
Table 41. Global Intracranial Drug Eluting Stents Revenue by Type (2017-2022) & (US$ Million)
Table 42. Global Intracranial Drug Eluting Stents Revenue Share by Type (2017-2022)
Table 43. Global Intracranial Drug Eluting Stents Price by Type (2017-2022) & (US$/Unit)
Table 44. Global Intracranial Drug Eluting Stents Sales (Units) by Application (2017-2022)
Table 45. Global Intracranial Drug Eluting Stents Sales Market Share by Application (2017-2022)
Table 46. Global Intracranial Drug Eluting Stents Revenue by Application (2017-2022) & (US$ Million)
Table 47. Global Intracranial Drug Eluting Stents Revenue Share by Application (2017-2022)
Table 48. Global Intracranial Drug Eluting Stents Price by Application (2017-2022) & (US$/Unit)
Table 49. Abbott Corporation Information
Table 50. Abbott Description and Business Overview
Table 51. Abbott Intracranial Drug Eluting Stents Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 52. Abbott Intracranial Drug Eluting Stents Product
Table 53. Abbott Recent Developments/Updates
Table 54. Medtronic Vascular Corporation Information
Table 55. Medtronic Vascular Description and Business Overview
Table 56. Medtronic Vascular Intracranial Drug Eluting Stents Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 57. Medtronic Vascular Intracranial Drug Eluting Stents Product
Table 58. Medtronic Vascular Recent Developments/Updates
Table 59. Advantec Vascular Corporation Information
Table 60. Advantec Vascular Description and Business Overview
Table 61. Advantec Vascular Intracranial Drug Eluting Stents Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 62. Advantec Vascular Intracranial Drug Eluting Stents Product
Table 63. Advantec Vascular Recent Developments/Updates
Table 64. B.Braun Melsengen Corporation Information
Table 65. B.Braun Melsengen Description and Business Overview
Table 66. B.Braun Melsengen Intracranial Drug Eluting Stents Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 67. B.Braun Melsengen Intracranial Drug Eluting Stents Product
Table 68. B.Braun Melsengen Recent Developments/Updates
Table 69. Boston Scientific Corporation Information
Table 70. Boston Scientific Description and Business Overview
Table 71. Boston Scientific Intracranial Drug Eluting Stents Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 72. Boston Scientific Intracranial Drug Eluting Stents Product
Table 73. Boston Scientific Recent Developments/Updates
Table 74. Terumo Medical Corporation Information
Table 75. Terumo Medical Description and Business Overview
Table 76. Terumo Medical Intracranial Drug Eluting Stents Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 77. Terumo Medical Intracranial Drug Eluting Stents Product
Table 78. Terumo Medical Recent Developments/Updates
Table 79. Biosensors Corporation Information
Table 80. Biosensors Description and Business Overview
Table 81. Biosensors Intracranial Drug Eluting Stents Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 82. Biosensors Intracranial Drug Eluting Stents Product
Table 83. Biosensors Recent Developments/Updates
Table 84. Biotronik Corporation Information
Table 85. Biotronik Description and Business Overview
Table 86. Biotronik Intracranial Drug Eluting Stents Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 87. Biotronik Intracranial Drug Eluting Stents Product
Table 88. Biotronik Recent Developments/Updates
Table 89. Blue Medical Corporation Information
Table 90. Blue Medical Description and Business Overview
Table 91. Blue Medical Intracranial Drug Eluting Stents Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 92. Blue Medical Intracranial Drug Eluting Stents Product
Table 93. Blue Medical Recent Developments/Updates
Table 94. DISA Vascular Corporation Information
Table 95. DISA Vascular Description and Business Overview
Table 96. DISA Vascular Intracranial Drug Eluting Stents Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 97. DISA Vascular Intracranial Drug Eluting Stents Product
Table 98. DISA Vascular Recent Developments/Updates
Table 99. Essen Corporation Information
Table 100. Essen Description and Business Overview
Table 101. Essen Intracranial Drug Eluting Stents Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 102. Essen Intracranial Drug Eluting Stents Product
Table 103. Essen Recent Developments/Updates
Table 104. MicroPort Medical Corporation Information
Table 105. MicroPort Medical Description and Business Overview
Table 106. MicroPort Medical Intracranial Drug Eluting Stents Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 107. MicroPort Medical Intracranial Drug Eluting Stents Product
Table 108. MicroPort Medical Recent Developments/Updates
Table 109. MIV Therapeutics Corporation Information
Table 110. MIV Therapeutics Description and Business Overview
Table 111. MIV Therapeutics Intracranial Drug Eluting Stents Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 112. MIV Therapeutics Intracranial Drug Eluting Stents Product
Table 113. MIV Therapeutics Recent Developments/Updates
Table 114. Orbusneich Corporation Information
Table 115. Orbusneich Description and Business Overview
Table 116. Orbusneich Intracranial Drug Eluting Stents Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 117. Orbusneich Intracranial Drug Eluting Stents Product
Table 118. Orbusneich Recent Developments/Updates
Table 119. Promed Medical Corporation Information
Table 120. Promed Medical Description and Business Overview
Table 121. Promed Medical Intracranial Drug Eluting Stents Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 122. Promed Medical Intracranial Drug Eluting Stents Product
Table 123. Promed Medical Recent Developments/Updates
Table 124. Relisys Medical Corporation Information
Table 125. Relisys Medical Description and Business Overview
Table 126. Relisys Medical Intracranial Drug Eluting Stents Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 127. Relisys Medical Intracranial Drug Eluting Stents Product
Table 128. Relisys Medical Recent Developments/Updates
Table 129. Reva Medical Corporation Information
Table 130. Reva Medical Description and Business Overview
Table 131. Reva Medical Intracranial Drug Eluting Stents Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 132. Reva Medical Intracranial Drug Eluting Stents Product
Table 133. Reva Medical Recent Developments/Updates
Table 134. Sahajanand Corporation Information
Table 135. Sahajanand Description and Business Overview
Table 136. Sahajanand Intracranial Drug Eluting Stents Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 137. Sahajanand Intracranial Drug Eluting Stents Product
Table 138. Sahajanand Recent Developments/Updates
Table 139. Sino Medical Corporation Information
Table 140. Sino Medical Description and Business Overview
Table 141. Sino Medical Intracranial Drug Eluting Stents Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 142. Sino Medical Intracranial Drug Eluting Stents Product
Table 143. Sino Medical Recent Developments/Updates
Table 144. Sorin Corporation Information
Table 145. Sorin Description and Business Overview
Table 146. Sorin Intracranial Drug Eluting Stents Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 147. Sorin Intracranial Drug Eluting Stents Product
Table 148. Sorin Recent Developments/Updates
Table 149. TEDA Corporation Information
Table 150. TEDA Description and Business Overview
Table 151. TEDA Intracranial Drug Eluting Stents Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 152. TEDA Intracranial Drug Eluting Stents Product
Table 153. TEDA Recent Developments/Updates
Table 154. Production Base and Market Concentration Rate of Raw Material
Table 155. Key Suppliers of Raw Materials
Table 156. Intracranial Drug Eluting Stents Distributors List
Table 157. Intracranial Drug Eluting Stents Customers List
Table 158. Intracranial Drug Eluting Stents Market Trends
Table 159. Intracranial Drug Eluting Stents Market Drivers
Table 160. Intracranial Drug Eluting Stents Market Challenges
Table 161. Intracranial Drug Eluting Stents Market Restraints
Table 162. Global Intracranial Drug Eluting Stents Sales Forecast by Type (2023-2028) & (Units)
Table 163. Global Intracranial Drug Eluting Stents Sales Market Share Forecast by Type (2023-2028)
Table 164. Global Intracranial Drug Eluting Stents Revenue Forecast by Type (2023-2028) & (US$ Million)
Table 165. Global Intracranial Drug Eluting Stents Revenue Market Share Forecast by Type (2023-2028)
Table 166. Global Intracranial Drug Eluting Stents Sales Forecast by Application (2023-2028) & (Units)
Table 167. Global Intracranial Drug Eluting Stents Sales Market Share Forecast by Application (2023-2028)
Table 168. Global Intracranial Drug Eluting Stents Revenue Forecast by Application (2023-2028) & (US$ Million)
Table 169. Global Intracranial Drug Eluting Stents Revenue Market Share Forecast by Application (2023-2028)
Table 170. Global Intracranial Drug Eluting Stents Sales Forecast by Region (2023-2028) & (Units)
Table 171. Global Intracranial Drug Eluting Stents Sales Market Share Forecast by Region (2023-2028)
Table 172. Global Intracranial Drug Eluting Stents Revenue Forecast by Region (2023-2028) & (US$ Million)
Table 173. Global Intracranial Drug Eluting Stents Revenue Market Share Forecast by Region (2023-2028)
Table 174. Research Programs/Design for This Report
Table 175. Key Data Information from Secondary Sources
Table 176. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Intracranial Drug Eluting Stents
Figure 2. Global Intracranial Drug Eluting Stents Market Share by Type in 2021 & 2028
Figure 3. Cobalt-chromium Alloy Stents Product Picture
Figure 4. Magnesium Alloy Stents Product Picture
Figure 5. Stainless Steel Stents Product Picture
Figure 6. Others Product Picture
Figure 7. Global Intracranial Drug Eluting Stents Market Share by Application in 2021 & 2028
Figure 8. Hospital
Figure 9. Specialty Clinic
Figure 10. Others
Figure 11. Global Intracranial Drug Eluting Stents Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 12. Global Intracranial Drug Eluting Stents Market Size (2017-2028) & (US$ Million)
Figure 13. Global Intracranial Drug Eluting Stents Sales (2017-2028) & (Units)
Figure 14. Intracranial Drug Eluting Stents Sales Share by Manufacturers in 2021
Figure 15. Global Intracranial Drug Eluting Stents Revenue Share by Manufacturers in 2021
Figure 16. The Global 5 and 10 Largest Intracranial Drug Eluting Stents Players: Market Share by Revenue in 2021
Figure 17. Intracranial Drug Eluting Stents Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2017 VS 2021
Figure 18. Global Intracranial Drug Eluting Stents Sales Market Share by Region (2017-2022)
Figure 19. Global Intracranial Drug Eluting Stents Sales Market Share by Region in 2021
Figure 20. Global Intracranial Drug Eluting Stents Revenue Market Share by Region (2017-2022)
Figure 21. Global Intracranial Drug Eluting Stents Revenue Market Share by Region in 2021
Figure 22. United States Intracranial Drug Eluting Stents Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 23. Canada Intracranial Drug Eluting Stents Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 24. Germany Intracranial Drug Eluting Stents Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 25. France Intracranial Drug Eluting Stents Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 26. U.K. Intracranial Drug Eluting Stents Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 27. Italy Intracranial Drug Eluting Stents Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 28. Russia Intracranial Drug Eluting Stents Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 29. China Intracranial Drug Eluting Stents Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 30. Japan Intracranial Drug Eluting Stents Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 31. South Korea Intracranial Drug Eluting Stents Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 32. India Intracranial Drug Eluting Stents Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 33. Australia Intracranial Drug Eluting Stents Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 34. China Taiwan Intracranial Drug Eluting Stents Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 35. Indonesia Intracranial Drug Eluting Stents Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 36. Thailand Intracranial Drug Eluting Stents Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 37. Malaysia Intracranial Drug Eluting Stents Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 38. Mexico Intracranial Drug Eluting Stents Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 39. Brazil Intracranial Drug Eluting Stents Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 40. Argentina Intracranial Drug Eluting Stents Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 41. Colombia Intracranial Drug Eluting Stents Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 42. Turkey Intracranial Drug Eluting Stents Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 43. Saudi Arabia Intracranial Drug Eluting Stents Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 44. UAE Intracranial Drug Eluting Stents Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 45. Sales Market Share of Intracranial Drug Eluting Stents by Type (2017-2022)
Figure 46. Manufacturing Cost Structure of Intracranial Drug Eluting Stents
Figure 47. Manufacturing Process Analysis of Intracranial Drug Eluting Stents
Figure 48. Intracranial Drug Eluting Stents Industrial Chain Analysis
Figure 49. Channels of Distribution
Figure 50. Distributors Profiles
Figure 51. Bottom-up and Top-down Approaches for This Report
Figure 52. Data Triangulation
Figure 53. Key Executives Interviewed
Buy
